Register entry
- Registered sites
- 0
- Active NDC listings
- 8
- Labeller names
- 3
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
88 active NDC listings: 8 human prescription drug. By marketing category: NDA 8.
| Dosage form | NDCs |
|---|---|
| tablet, film coated, extended release | 3 |
| capsule | 2 |
| powder, for suspension | 2 |
| tablet, extended release | 1 |
| Route | NDCs |
|---|---|
| oral | 8 |
| Labeller name on the listing | NDCs |
|---|---|
| santarus, inc.. | 4 |
| santarus, inc. | 3 |
| santarus inc. | 1 |
Catalogue
Marketed products
8| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Glumetza | metformin hydrochloride | tablet, film coated, extended release, oral | 68012-002NDA |
| Glumetza | metformin hydrochloride | tablet, film coated, extended release, oral | 68012-003NDA |
| Glumetza | metformin hydrochloride | tablet, film coated, extended release, oral | 68012-004NDA |
| Uceris | budesonide | tablet, extended release, oral | 68012-309NDA |
| ZEGERID | omeprazole and sodium bicarbonate | powder, for suspension, oral | 68012-052NDA |
| ZEGERID | omeprazole and sodium bicarbonate | powder, for suspension, oral | 68012-054NDA |
| ZEGERID | omeprazole and sodium bicarbonate | capsule, oral | 68012-102NDA |
| ZEGERID | omeprazole and sodium bicarbonate | capsule, oral | 68012-104NDA |
Compare
Other companies listing omeprazole and sodium bicarbonate
- Azurity Pharmaceuticals, Inc.0 sites · 61 NDC
Enquiry
Common questions
- Is Santarus, Inc.. FDA approved?
- Santarus, Inc.. holds no registered establishment of its own; 8 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Santarus, Inc.. make?
- 8 products are listed under Santarus, Inc.. in the openFDA NDC Directory, most often as tablet, film coated, extended release; capsule; powder, for suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.